🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the long term safety of SCH 420814 (...
Status
Completed
Location
Multiple Locations
Start Date
2007-11-23
Trial ID
NCT00537017
Treatments Being Tested
This study is designed to evaluate the effectiveness of preladenant in the ...
Status
Terminated
Location
Multiple Locations
Start Date
2007-08-15
Trial ID
NCT00693472
Treatments Being Tested
This is a one year, 2-part study to determine the efficacy and safety of pr...
Status
Terminated
Location
Multiple Locations
Start Date
2010-07-06
Trial ID
NCT01155479
This study is to evaluate the efficacy of a range of preladenant doses comp...
Status
Completed
Location
Multiple Locations
Start Date
2011-02-25
Trial ID
NCT01294800
Treatments Being Tested
The primary purpose of this extension study is to assess the long-term safe...
Status
Terminated
Location
Multiple Locations
Start Date
2010-11-18
Trial ID
NCT01215227
Treatments Being Tested
The purpose of this study is to compare the pharmacokinetics (PK) of prelad...
Status
Completed
Location
Multiple Locations
Start Date
2011-11-10
Trial ID
NCT01465412
Treatments Being Tested
This study was designed to determine if preladenant (SCH 420814, MK-3814) c...
Status
Terminated
Location
Multiple Locations
Start Date
2006-07-10
Trial ID
NCT00686699
Treatments Being Tested
When a patient with Parkinson's disease (PD) is initially treated with L-do...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-14
Trial ID
NCT01155466
This is a randomized, placebo-controlled, 3-period crossover, balanced, sin...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-21
Trial ID
NCT00845000
Treatments Being Tested
The purpose of this study is to evaluate the safety and preliminary efficac...
Status
Terminated
Location
START Midwest ( Site 0001)
Start Date
2017-06-27
Trial ID
NCT03099161
Treatments Being Tested